703 results found

This expansion stems from increasing needs for sophisticated diagnostic capabilities, optimized treatment methodologies, and personalized patient care approaches.

Recently, there was a huge debate going-on both at the state and center level regarding online sales of the medicine.

The Lok Sabha passed The Prohibition of Electronic Cigarettes (Production, Manufacture, Import, Export, Transport, Sale, Distribution, Storage and Advertisement) Bill, 2019 on 27 November 2019 seeking the prohibition ...

A Biosimilar Bevacizumab for Treating Several Types of Cancer

On 3 September 2020, the Central Drugs Standard Control Organization (CDSCO), the national regulatory body for Indian pharmaceuticals and medical devices released draft classifications for newly notified devices.

The Drugs and Cosmetics Act, 1940 ("Act") is the primary legislation governing the manufacture, sale, distribution and import of drugs and cosmetics in India.

To drive economic growth and advance social progress in line with India's vision for Viksit Bharat, it is crucial to examine the alarming rise of the illegal tobacco market in India.

Health tech can be considered as an ever evolving and most significant field for mankind. More than, $21.6 Billion have been invested in digital healthcare companies in the year 2020.

Advancements in science has deeply impacted modern life. Innovation in technology has played a significant role in improving our health.

The Employee State Insurance Corporation ("ESIC") has formulated the Standard Operating Procedure ("SOP") for prescription writing to enhance healthcare quality and patient safety while achieving therapeutic goals...

On April 7 2017, the President gave his vote to the Mental Healthcare Bill and with that the MENTAL HEALTH CARE ACT 2017 came to existence.

Under Trade-Related Aspects of Intellectual Property Rights (TRIPS)' there was no access to medicines for underdeveloped countries for treating serious health issues.

This segment of the newsletter shares recent information related to regulatory reforms from Healthcare and Pharmaceutical sectors in India.

This segment of the newsletter shares recent information related to regulatory reforms from Healthcare and Pharmaceutical sectors in India.

. Out of this, an amount of INR 5.56 crore has been recovered and demand notices amounting to INR 89.31 crore are under litigation.

On April 22, 2019, a MOU was signed between the Ministry of AYUSH and CSIR for cooperation in research, education and interdisciplinary sciences that integrate/co-opt traditional systems of medicine and modern science.

Globally, pneumonia causes more than a quarter of deaths in children under the age of five – that is nearly one million young lives lost per year.